Advertisement

Topics

Latest "Sumika Fine Chemicals Company Limited" News Stories

21:27 EDT 21st June 2018 | BioPortfolio

Here are the most relevant search results for "Sumika Fine Chemicals Company Limited" found in our extensive news archives from over 250 global news sources.

More Information about Sumika Fine Chemicals Company Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Sumika Fine Chemicals Company Limited for you to read. Along with our medical data and news we also list Sumika Fine Chemicals Company Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sumika Fine Chemicals Company Limited Companies for you to search.

Showing "Sumika Fine Chemicals Company Limited" News Articles 1–25 of 17,000+

Thursday 21st June 2018

The Chemours Company Announces Future of Chemistry Scholarship for Wilmington-Area Students ...

Chemours awarded the inaugural Future of Chemistry Scholarshipto Iyana Cain, a recent graduate of A. I. DuPont High School. In the fall, she Read more...


Global Water Treatment Chemicals Market Report 2018

The global water treatment chemicals market to grow at a CAGR of 7.01% during the period 2018-2022. Global Water Treatment Chemicals Market 2018-2022, has been Read more...

Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for Second Quarter 2018 Earnings Release and Conference Call

Physicians Realty Trust (NYSE:DOC) (the “Company”) announced today that the Company’s Board of Trustees has authorized and the Company has declared a quarterly cash dividend of $0.23 per common share and unit for the quarter ending June 30, 2018. “We are proud to declare and pay our 20th consecutive quarterly dividend. Medical office remai...


Lantheus Holdings to Present at the CJS Securities 18th Annual “New Ideas” Summer Conference

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced that Mary Anne Heino

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

  NANOBIOTIX ANNOUNCES POSITIVE PHASE II/III TOPLINE DATAIN SOFT TISSUE SARCOMA WITH NBTXR3 Trial achieved its primary endpoint of pathological Complete Response Rate Trial achieved its secondary endpoint in operability (R0 rate) NBTXR3 demonstrated significant superiority and clinical benefits for patients versus standard of care

Harvest One Welcomes the Passage of Bill C-45 and the Announced Legalization Date of Cannabis in Canada

Harvest One Cannabis Inc. (TSXV:HVT) ("Harvest One" or the "Company") provided the following statement on Bill-C45, the landmark cannabis act that will legalize cannabis in Canada on October 17, 2018: The post Harvest One Welcomes the Passage of Bill C-45 and the Announced Legalization Date of Cannabis in Canada appeared first on Investing News Network.

Fixing Part D Coverage Gap ‘Cliff’ Is Right Way To Lower Costs, PhRMA Says

PhRMA pushing for legislation to address upcoming surge in Medicare Part D out-of-pocket spending requirements and reverse the recently-enacted increase...   

Oral Contraceptive OTC Proposal Moves Closer With Start Of Actual Use Study

HRA Pharma started recruiting in April for an actual use trial, using oral contraceptives with norgestrel 0.075 mg, and expec...

AMA Encourages Oral Contraceptive OTC Options In Policy Update

AMA members agree to strengthen association's policy language supporting approval and reimbursement of OTC contraceptives...

Kalytera Provides Update on its Cannabis-Based Therapy for Prevention and Treatment of GVHD

SAN FRANCISCO and TEL AVIV, Israel, June 21, 2018 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX-V:KALY) and (OTCQB:KALTF) (the “Company” or “Kalytera”) today provided an update on its lead clinical development program evaluating cannabidiol (“CBD”) for the prevention and treatment of acute graft versus host disease (“GVHD”). GVHD is a lif...

US FDA Fine-Tunes Tecentriq, Keytruda First-Line Bladder Cancer Accelerated Approval Indications

FDA’s decision to restrict use based on the level of PD-L1 expression shows how confirmatory trials for accelerated approval can...   

Shire Receives U.S. FDA Approval for New State-of-the-Art Plasma Manufacturing Facility Near Covington, Georgia

Shire Receives U.S. FDA Approval for New State-of-the-Art Plasma Manufacturing Facility Near Covington, Georgia New facility will add 30% capacity to Shire's internal plasma manufacturing network once fully operational Expanded capacity supports continued strong growth of Shire's leading immunoglobulin portfolio and further strengthens ability to deliver complex the...

PAION AG RAISES EUR 5.2 MILLION IN PRIVATE PLACEMENT

PAION AG / Key word(s): Capital Increase PAION AG RAISES EUR 5.2 MILLION IN PRIVATE PLACEMENT 21-Jun-2018 / 17:53 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDI...

Blue Cross Blue Shield Plan Administrative Costs Accelerated in 2017

Blue Cross Blue Shield Plans had administrative cost increases of 5.9% in 2017, far higher than the previous three years, and the highest since 2013. Last year’s increase was 0.6%. Increases are calculated for continuously participating Plans, after backing out the effect of mix changes. On an as-reported basis, per member costs grew by 5.1% com...

PhoreMost and o2h discovery collaborate to progress first-in-class drug discovery programs.

Cambridge, UK, 21 June 2018: PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage. PhoreMost has built a pipeline of novel...

Tenet Healthcare Announces Results for 2018 Healthy Over Hungry® Cereal Drive

More than 225 facilities and offices collected five million servings of cereal and $380,000 Contributions will benefit Feeding America® and more than 100 non-profit organizations in communities across the United States Since 2014, 15 million servings of cereal and approximately $1 million have been collected Tenet Healthcare C...

Eckert & Ziegler BEBIG: Meeting Minutes Annual General Meeting

Seneffe, June 21, 2018. The Minutes and all relevant documents regarding the Annual General Assembly 2018 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About Eckert & Ziegler BEBIG Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) is a European-based group active in the medical device segment of the...

BBS-Bioactive Bone Substitutes Plc: BBS's ARTEBONE® -product as an example in the Manual of classification of medical devices

BBS-Bioactive Bone Substitutes Plc. COMPANY ANNOUNCEMENT 21.6.2018 BBS's ARTEBONE® -product as an example in the Manual of classification of medical devices The European Commission has published an updated version of the Manual of classification of medical devices (MANUAL ON BORDERLINE AND CLASSIFICATION IN THE COMMUNITY REGULATORY FRAMEWORK FOR MEDICAL DEVICES). In the Manual th...

Aino Health AB (publ): Aino HealthManager is live with ArcelorMittal

Aino Health's IT platform HealthManager has gone live to support ArcelorMittal's operations in Neuwied, Germany. This is a joint implementation project with ArcelorMittal and Aino Health that is comprised of process definition, technical IT integration, training of management as well as communications. - Aino Health has now proven that its solutions are fit for the Germ...

Curetis Reports Results of the Annual General Meeting Held on June 21, 2018

Curetis / Curetis Reports Results of the Annual General Meeting Held on June 21, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis Reports Results of the Annual General Meeting Held on June 21, 2018 - All proposed AGM resolutions approved by shareholders Amsterdam, the Netherlands, Holzge...

RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand

RISE Life Science Corp. (CSE:RLSC) (the "Company" and/or "RISE") today announced the launch of its CBD-based wellness brand, Karezza, at retail in California as of June 20, 2018. The post RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand appeared first on Investing News Network.

Discontinued Endologix AAA Graft Device Singled Out In Updated FDA Alert

US FDA says that previously identified elevated risks of type III endoleaks from endovascular aneurysm repair systems appears to be...   

Prosten Health Holdings Limited officially renamed as "China Brilliant Global Limited"

HONG KONG, June 21, 2018 /PRNewswire/ -- Prosten Health Holdings Limited ("the Company"; Stock code: 08026) is pleased to announce the Company has officially renamed as "China Brilliant Global Limited" (referred to as "China Brilliant") with effect from 20 June 2018. China Brilliant has been striving for diversified development. Looking ahead, the Company will furth...

Risk Level For Harmful Chemicals In Drinking Water Needs To Be 7-to-10 Times Lower Than EPA Recommended, Study Finds

“This study confirms that the EPA’s guidelines for PFAS levels in drinking water woefully underestimate risks to human health,” said Olga Naidenko, senior science adviser at the Environmental Working Group. Other news on the safety of drinking water comes from New York and Cleveland.

Dow, University of Michigan, Delta College Collaborate to Create New Innovation and Education Hub in the Great Lakes Bay Region

Delta College Announces Construction of New Campus Building in Downtown Midland; Dow, U-M Partner to Launch Andrew N. Liveris Innovation Institute; Collaboration Highlights Ongoing Commitment to Invest in the Great Lakes Bay Region The Dow Chemical Company (Dow), the University of Michigan (U-M) and ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks